🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Global vision meets regional impact! The APAC Leadership Session at SACT 2025 - pioneers. and industry leaders on thriving Cell & Gene Therapy ecosystem. Dynamic dialogue on innovation, access, and the future of CGT in APAC. Gaurav Narula MD Albeena Nisar Danny Soon Shin Kawamata

Officially opening the doors to #SACT2025 wherein cutting-edge advancements in CGT take center stage. Join global pioneers as we push the frontiers of science, innovation, and clinicaltranslation.Gaurav Narula MD Albeena Nisar Dr.Navin Khattry Dr Jitendra Kumar Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉

More from the Inaugural Ceremony, #SACT2025- The appetite for the field is humongous. Pioneers in the field, Gaurav Narula MD Albeena Nisar Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 Dr. Katy Rizwani, Dr. Navin Khattry, Dr. Jitendra Kumar, Dr Emily Hopewell, Dr. Elizebeth Shpall in frame. CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC @KhushaliPandi

Live from #SACT2025! The grand inaugural ceremony sets the stage for a transformative journey in Cell & Gene Therapy. Stay tuned as we unlock more! #CellTherapy #APAC Gaurav Narula MD Albeena Nisar Alok Srivastava Dr. Navin Khattry CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC #CGT Tata Memorial Hospital ACTREC-TMC

Dr. Levine’s Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 plenary talk at #SACT25 explored the next frontier of CAR-T therapy-in vivo delivery. Highlights a transformative shift - one that could redefine accessibility, efficacy, and scalability of these life-saving treatments. Gaurav Narula MD Albeena Nisar CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC

A dynamic panel discussion at #SACT2025, led by Dr. Albeena Nisar, on the future of CAR-T therapy beyond blood cancers. Engaging insights on solid tumor challenges, manufacturing hurdles, and regulatory advancement. Gaurav Narula MD Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 Albeena Nisar

Day2, #SACT25 Momentum in the CGT space is unstoppable! With a full house and soaring energy, we continue to push boundaries, drive innovation, and shape the future of #CGT Dr.Hopewell, Dr. Rizvani, Dr. Feldman, Dr. Ghosh. Albeena Nisar Gaurav Narula MD Khushali Pandit

From the lab to the track, we’re racing toward a future where cell and gene therapies transform lives. This incredible initiative is a major highlight of APAC – #SACT2025, bringing together pioneers from all.Gaurav Narula MD Albeena Nisar Dr Geeta Jotwani, CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Khushali Pandit

#SACT2025- Hearing from a frontier in the field is always invaluable, and her perspective resonated deeply with those driving the future of cell and gene therapies. Dr. Katy Rezvani sheds light on #CGT innovation and leadership. Gaurav Narula MD Albeena Nisar Khushali Pandit

A dazzling array of First-in-Human NK cell based trials by the thought and action leader in the field Katy Rezvani, M.D., Ph.D So much done in the last decade and she’s just getting started Wonderful session at SACT 2025 (Series on Advancements in Cell Therapy)

Day 2 at #SACT2025 features a dynamic panel on “Cell Therapy Solutions for Every Step – from Discovery to Cure,” moderated by Gaurav Narula MD . Powerhouse panel including Katy Rezvani, M.D., Ph.D Dr. Elizabeth Shpall,Dr.Tembhare,and Dr.Kanagal-Shamanna-Albeena Nisar Khushali Pandit CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC

Women belong in every lab, every breakthrough, every discovery! At #SACT2025, we celebrated #WomenInScience on #WomensDay—honoring pioneers & uplifting young scientists. Huge thanks to Albeena Nisar for leading and making this more meaningful#WomenInSTEM #SACT” Gaurav Narula MD

#SACT2025 united industry leaders in #CGT, fostering groundbreaking partnerships & innovations. The exhibition floor buzzed with cutting-edge solutions CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC MakeInIndia Miltenyi Laszlo Thermo Fisher Cytiva Agilent Technologies linkedin.com/posts/sact-ser… #SACT2025: Gaurav Narula MD Albeena Nisar

2012 a friend said- “Science Fiction” 2015 we dared to dream Sharing 🇮🇳 1st novel #CARTCellRx Ph 1/1b trial We report 92% ORR 3 dose levels nature Blood Cancer Journal Rahul Purwar ImmunoACT CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC Nirali Shah Tata Memorial Hospital Swaminathan K Alka Dwivedi rdcu.be/ei7xh

Exciting milestone in CAR T Cell Therapy for pediatric patients!!! rdcu.be/ei7xh Gaurav Narula MD Albeena Nisar deepalipandit1993 Rahul Purwar Atharva Karulkar Tata Memorial Hospital ACTREC-TMC IIT Bombay ImmunoACT

#2 we used stringent MRD CR = 67% At Dose > 3mill/kg CR of 88% & sustained Pts were heavily pretreated incl post 2 SCTs Non CRs at ⬇️ doses ⬆️pre-CAR marrow blasts (>20%) Similar for toxicities which were overall low P2D 5-10 mill/kg Ph2 completing Do read Feedback welcome🙏

Happy to share an excellent ORR at three dose levels in pediatric patients with HCAR19, India’s first CD19 CAR T. Do read the article rdcu.be/ei7xh

#3/3 Good expansion & persistence of #CART in-vivo & Cytokine production low- Outlier Pt with pre-infusion #Covid19 CART dynamics studied by Flowcytometry Prashant Tembhare Pgs_mani Day +5 sample post Infusion we first saw the #CAR T in circulation- & knew it was working

Congratulations Gaurav Narula MD Sir and team ACTREC-TMC and IIT Bombay for this monumental achievement. The journey is indeed an inspirational one. Rahul Purwar Albeena Nisar Khushali Pandit CAR-T & Cell Therapy Centre (CTCTC) ACTREC_TMC

📝 A new study published in The Lancet Haematology found that talicabtagene autoleucel could enable low-cost delivery and improved access to CAR T-cell therapy for patients with R/R B-cell malignancies in low-resource settings. 👉 loom.ly/LDBSS10 #lymphoma #lymsm #MedNews #MedEd